Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group.
Undre
N A
NA
European Tacrolimus Multicentre Renal Study Group, Fujisawz GmbH, Munich, Germany.
Schäfer
A
A
D000328:Adult; D000368:Aged; D016903:Drug Monitoring; D005500:Follow-Up Studies; D006400:Hematocrit; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D012044:Regression Analysis; D012709:Serum Albumin / Q000032:analysis; D016559:Tacrolimus / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D013997:Time Factors
D007166:Immunosuppressive Agents; D012709:Serum Albumin; D016559:Tacrolimus